575 – Continuous Increase in HIV-1 Resistance to Neutralization by bNAbs Over the Past 30 Years
Background The efficacy of broadly neutralizing antibodies (bNAbs) is affected by the genetic diversity of HIV-1 and the ongoing escape from autologous neutralizing Abs at the population level. We investigated the current state of neutralization sensitivity of recent transmitted/founder (T/F) variants, with a focus on subtype B and CRF02_AG, the predominant clades in North America,…